MDL-29951

MDL-29951
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T1897-1mg 1 mg

7 - 10 business days*

71.00€
TGM-T1897-2mg 2 mg -

7 - 10 business days*

95.00€
TGM-T1897-5mg 5 mg

7 - 10 business days*

173.00€
TGM-T1897-1mL 1 ml

7 - 10 business days*

179.00€
TGM-T1897-10mg 10 mg

7 - 10 business days*

310.00€
TGM-T1897-25mg 25 mg

7 - 10 business days*

561.00€
TGM-T1897-50mg 50 mg

7 - 10 business days*

806.00€
TGM-T1897-100mg 100 mg

7 - 10 business days*

1,108.00€
 
Description: MDL-29951 is a novel glycine antagonist for NMDA receptor activation. Target:... more
Product information "MDL-29951"
Description: MDL-29951 is a novel glycine antagonist for NMDA receptor activation. Target: iGluR, NMDAR. Smiles: OC(=O)CCc1c([nH]c2cc(Cl)cc(Cl)c12)C(O)=O. References: Baron BM, et al. Potent indole- and quinoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding site. J Pharmacol Exp Ther. 1992 Sep,262(3):947-56.
Supplier: TargetMol
Supplier-Nr: T1897

Properties

Application: FBP inhibitor
MW: 302.11 D
Formula: C12H9Cl2NO4

Database Information

CAS : 130798-51-5| Matching products
KEGG ID : K03841 | Matching products

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "MDL-29951"
Write a review
or to review a product.
Viewed